Exact Mass: 361.18641020000007
Exact Mass Matches: 361.18641020000007
Found 161 metabolites which its exact mass value is equals to given mass value 361.18641020000007,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Carbocromen
C20H27NO5 (361.18891320000006)
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
rac S 33138
1alphaH,5alphaH,6betaH,7alphaH,11betaH-3beta-hydroxy-11alpha-[(tetrahydro-5-oxo-furan-2-yl)methylamino]methylguaia-4(15),10(14)-dien-12,6-olide|scorzoaustriacin
C20H27NO5 (361.18891320000006)
2alpha-methoxy-6-O-methyllycorenine
C20H27NO5 (361.18891320000006)
Ala Gly Lys Ser
Ala Gly Ser Lys
Ala Lys Gly Ser
Ala Lys Ser Gly
Ala Ser Gly Lys
Ala Ser Lys Gly
Gly Ala Lys Ser
Gly Ala Ser Lys
Gly Gly Lys Thr
Gly Gly Thr Lys
Gly Lys Ala Ser
Gly Lys Gly Thr
Gly Lys Ser Ala
Gly Lys Thr Gly
Gly Ser Ala Lys
Gly Ser Lys Ala
Gly Thr Gly Lys
Gly Thr Lys Gly
Lys Ala Gly Ser
Lys Ala Ser Gly
Lys Gly Ala Ser
Lys Gly Gly Thr
Lys Gly Ser Ala
Lys Gly Thr Gly
Lys Ser Ala Gly
Lys Ser Gly Ala
Lys Thr Gly Gly
Ser Ala Gly Lys
Ser Ala Lys Gly
Ser Gly Ala Lys
Ser Gly Lys Ala
Ser Lys Ala Gly
Ser Lys Gly Ala
Thr Gly Gly Lys
Thr Gly Lys Gly
Thr Lys Gly Gly
Cinchonan-9-amine, 10,11-dihydro-6-methoxy-, trihydrochloride , (9R)
C20H28ClN3O (361.19207880000005)
3,3-diphenyl-N-(3-phenylsulfanylpropyl)propan-1-amine
N-([1,1-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine
N-[1,1-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine
N-[1,1-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine
2-(diethylamino)ethyl 2,2-diphenylpropanoate,hydrochloride
C21H28ClNO2 (361.18084580000004)
4-((4-(DIETHYLAMINO)PHENYL)IMINO)-N-METHYL-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBOXAMIDE
5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole
2-(1-(tert-Butoxycarbonyl)spiro[chroman-2,4-piperidine]-4-yl)acetic acid
C20H27NO5 (361.18891320000006)
buquinolate
C20H27NO5 (361.18891320000006)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Bradanicline
C78272 - Agent Affecting Nervous System Bradanicline is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (humanα7 nAChR: EC50=17 nM; Ki= 1.4 nM). Bradanicline is used for the research of cognitive disorders[1][2].
1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea
PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM[1][2][3].
Etafenone hydrochloride
C21H28ClNO2 (361.18084580000004)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-[(4-phenyl-1-piperazinyl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one
4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one
3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide
4-[(3aR,4S,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
[(2R,3S,4S)-1-(4-ethyl-2-thiazolyl)-4-[(2-methoxyethylamino)methyl]-3-phenyl-2-azetidinyl]methanol
4-[(3aS,4R,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aR,4R,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aS,4S,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
carbocromen
C20H27NO5 (361.18891320000006)
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
H-Ile-Pro-Pro-OH (hydrochloride)
H-Ile-Pro-Pro-OH hydrochloride, a milk-derived peptide[1], inhibits angiotensin-converting enzyme (ACE)[1] with an IC50 of 5 μM[2]. Antihypertensive tripeptides[1].
SR59230A (hydrochloride)
C21H28ClNO2 (361.18084580000004)
SR59230A hydrochloride is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist[1] with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively[2].
4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-13,16-diol
C20H27NO5 (361.18891320000006)
3-(acetyloxy)-1-[(10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl 2-methylbutanoate
C20H27NO5 (361.18891320000006)
(1r,4r,5r,13s,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate
C20H27NO5 (361.18891320000006)
1-(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl (2r)-2-benzyl-2-hydroxybutanedioate
C20H27NO5 (361.18891320000006)
n-{5-[(2r,3s,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid
C20H27NO5 (361.18891320000006)
(1s,2s,5s,8s,9s,10s,11r,15s,18r)-9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-17-azapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadec-16-en-7-one
C20H27NO5 (361.18891320000006)
(1r,4r,5r,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate
C20H27NO5 (361.18891320000006)
3-(acetyloxy)-1-{8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene}butan-2-yl 2-methylbutanoate
C20H27NO5 (361.18891320000006)
n-{5-[(2z,4s,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid
C20H27NO5 (361.18891320000006)
5-[({[(3r,3as,6ar,8s,9ar,9bs)-8-hydroxy-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-3-yl]methyl}amino)methyl]oxolan-2-one
C20H27NO5 (361.18891320000006)
(2s,3r)-3-(acetyloxy)-1-[(1s,3r,10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl (2s)-2-methylbutanoate
C20H27NO5 (361.18891320000006)
14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaene-10-carboxamide
(1r,2s,3s,5r,6r,8r,9s,11r,14s,16s,17s,18s,19r)-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol
C20H27NO5 (361.18891320000006)
n-{5-[(2r,3r,4e,6z)-2,8-dihydroxy-7-[(1z)-prop-1-en-1-yl]octa-4,6-dien-3-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid
C20H27NO5 (361.18891320000006)
(1s,8s,10r,17s)-4,5,6,8-tetramethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraene
C20H27NO5 (361.18891320000006)
5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-2,3,6,18,19-pentol
C20H27NO5 (361.18891320000006)
4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol
C20H27NO5 (361.18891320000006)
1-hexahydro-1h-pyrrolizin-1-ylmethyl 4-methyl 2-benzyl-2-hydroxybutanedioate
C20H27NO5 (361.18891320000006)
n-{5-[(2z,4r,5e,7r)-1,7-dihydroxy-2-[(1z)-prop-1-en-1-yl]octa-2,5-dien-4-yl]-4-hydroxy-2-methoxyphenyl}ethanimidic acid
C20H27NO5 (361.18891320000006)
(1s,10s,13s)-4,11,12-trimethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-3,13-diol
C20H27NO5 (361.18891320000006)